EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders
-
Published:2024-08-29
Issue:
Volume:
Page:
-
ISSN:1619-7070
-
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
-
language:en
-
Short-container-title:Eur J Nucl Med Mol Imaging
Author:
Nanni Cristina, Deroose Christophe M., Balogova Sona, Lapa Constantin, Withofs Nadia, Subesinghe Manil, Jamet Bastien, Zamagni ElenaORCID, Ippolito Davide, Delforge Michel, Kraeber-Bodéré Francoise
Abstract
AbstractWe provide updated guidance and standards for the indication, acquisition, and interpretation of [18F]FDG PET/CT for plasma cell disorders. Procedures and characteristics are reported and different scenarios for the clinical use of [18F]FDG PET/CT are discussed. This document provides clinicians and technicians with the best available evidence to support the implementation of [18F]FDG PET/CT imaging in routine practice and future research.
Funder
Alma Mater Studiorum - Università di Bologna
Publisher
Springer Science and Business Media LLC
Reference114 articles.
1. van de Donk, Niels WCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet (Br Ed). 2021. https://doi.org/10.1016/S0140-6736(21)00135-5. 2. Zamagni E, Barbato S, Cavo M. How I treat high-risk multiple myeloma. Blood. 2022. https://doi.org/10.1182/blood.2020008733. 3. Caers J, Garderet L, Kortüm KM, O'Dwyer ME, van de Donk, Niels WCJ, Binder M, Dold SM, Gay F, Corre J, Beguin Y, Ludwig H, Larocca A, Driessen C, Dimopoulos MA, Boccadoro M, Gramatzki M, Zweegman S, Einsele H, Cavo M, Goldschmidt H, Sonneveld P, Delforge M, Auner HW, Terpos E, Engelhardt M. European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica (Roma). 2018. https://doi.org/10.3324/haematol.2018.189159. 4. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, Leleu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BGM, San Miguel JF. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. 2014. https://doi.org/10.1016/S1470-2045(14)70442-5. 5. Greipp PR, San Miguel J, Lahuerta JJ, Ludwig H, Morgan G, Powles R, Shimizu K, Shustik C, Sonneveld P, Tosi P, Turesson I, Westin J, Durie BGM, Crowley JJ, Barlogie B, Blade J, Boccadoro M, Child JA, Harousseau J, Kyle RA. International staging system for multiple myeloma. 2005. https://doi.org/10.1200/JCO.2005.04.242.
|
|